Most medical device manufacturers invest heavily in translation during the pre-market phase, localising IFUs, labels, and packaging across EU member states ahead of CE marking. That effort is visible, deadline-driven, and budgeted. What comes after is far less visible...
Medical
What EU MDR Actually Requires on Your Medical Device Label
Europe accounts for around 26.4% of the global medical device market. For manufacturers entering the EU, label compliance is one of the practical requirements to get right, and one that is frequently misread. Many manufacturers approach the physical medical device...
Proposed Changes to EU MDR and IVDR: What It Means for Translations
The European Commission wants to simplify medical device regulations. Everyone is talking about reduced burden, but will you actually translate less? The short answer: probably not. In fact, you may end up translating more. While the proposal introduces potential...
EUDAMED Translation Requirements for Medical Device Manufacturers
The EU just set a hard deadline for EUDAMED. Starting May 28, 2026, manufacturers must use EUDAMED for registration across four modules. Translation becomes a critical requirement for market access. Manufacturers must provide device information, instructions for use,...
Language Regulations for Pharmaceutical Products under Swissmedic
For pharmaceutical companies entering the Swiss market, complying with Switzerland’s regulatory framework is essential to ensure patient safety, product quality, and market access. Swissmedic, as the national authority that governs all medicinal products through the...
Swissmedic Language Requirements for Medical Device Documentation
For medical device and In Vitro Diagnostics manufacturers entering the Swiss market, complying with Switzerland’s regulatory framework is essential for patient safety, quality, and market access. After Switzerland’s separation from the EU system, Swissmedic introduced...
MHRA Language Requirements for Clinical Trial Documents
The UK’s clinical trial framework is governed by the Medicines and Healthcare products Regulatory Agency (MHRA), which ensures that studies are conducted safely, ethically, and transparently. A key aspect of this framework is its focus on clear and accurate language...
EU CTR 536/2014: Translation Requirements
The EU Clinical Trial Regulation (EU CTR 536/2014) is a comprehensive framework designed to enhance the safety, transparency, and efficiency of clinical trials conducted across the European Union. A key aspect of this regulation is its emphasis on clear, accurate...
MDD vs MDR: Key Differences in Translation and Language Requirements
For medical device manufacturers aiming to access the European market, complying with evolving regulations is essential to ensure patient safety, maintain quality standards, and stay competitive. With growing demands for transparency and patient safety, the European...









